NovoCure Ltd

Market cap: $6,145,478,883

Exchange: NAS

Sector: Health Technology

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

STOCK PRICE CHART

Key Statistics

Company Name

NovoCure Ltd

Average Volume (10 days)

1,223,605

Average Volume (30 days)

864,445

Moving Average (50 days)

$71.16

Moving Average (200 days)

$75.93

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-104.3907

Market Cap

6,145,478,883

Shares Outstanding

104,586,094

52-Week High Split Adjust Only

232.76

52-Week Low Split Adjust Only

56.39

Employee Count

1,023

Beta

1.776

Next Earnings Date

2022-07-28

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.02%

Past 30 days

-0.21%

Past 3 months

-0.25%

Past 6 months

-0.31%

Past year

-0.73%

Past 2 years

-0.07%

Past 5 years

2.36%

Max % Change

2.21%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
NovoCure LtdNVCR25.5335.021.625.5324.91
Peer AvgN/A3.324.5714.63.323.21
Neurocrine Biosciences, Inc.NBIX8.707.5544.78.708.17
Maravai LifeSciences Holdings Inc - Class AMRVI4.5810.7120.34.584.69
MeiraGTx Holdings plcMGTXn/an/a-6.8n/an/a